Nuestras Publicaciones

Listado de Publicaciones en Cardiopatias Familiares

1. JF Parra-Cuadrado, M Gomez del Moral, P García-Pavía, F Setién y E Martinez-Naves. Characterization of the MHC class I-related MR1 locus in nonhuman primates. Immunogenetics 2001; 53:643-8.

2. P García-Pavía, J García Pérez, D García Rodriguez, J González Mirelis y J García Puig. Ahorro derivado de la participación en ensayos clínicos. Rev Clin Esp 2002; 202:66-72.

3. P García-Pavía, RJ Torres, M Ahmed, M Rivero, JG Puig y MA Becker. Phosphoribosylpyrophospate Synthetase Overactivity as a cause of Uric Acid Overproduction in a Young Woman. Arthritis Rheum 2003; 48:2036-41.

4. P Aguiar-Souto, P García-Pavía, JR Peraira-Moral y M Cobo-Marcos. Mejoría electrocardiográfica tras intervencionismo coronario. Med Clin (Barc) 2005;125:440.

5. P Garcia-Pavia, P Aguiar-Souto, L Silva-Melchor. Management of Acute Coronary Syndromes. N Eng J Med 2005;353: 2716.

6. P García-Pavía, J González-Mirelis, R Pastorin, M Bruna, J Raez, AI Tabuenca, L Alonso-Pulpón y JR Banegas. Análisis de las áreas de mejora del control de la hipertensión arterial en Atención Primaria. Rev Clin Esp 2006;206:220-4.

7. P Aguiar-Souto, P García-Pavía, L Silva-Melchor, FJ Ortigosa-Aso. Diagnosis and Management of Chronic Heart Failure. J Am Coll Cardiol 2006;48:223.

8. L Silva-Melchor, P Garcia-Pavia, J Ortigosa. Resincronización y prevención de la muerte súbita en la insuficiencia cardiaca. De los ensayos a la práctica clínica. Rev Esp Cardiol 2006;6(Supl.F):59-70.

9. P Garcia-Pavia, P Aguiar-Souto, L Silva-Melchor, MA Cavero, M Pastrana, J Goicolea, L Alonso-Pulpón. Cardiac Magnetic Resonance Imaging in the diagnosis of Myocarditis mimicking Myocardial Infarction. Int J Cardiol 2006;112:e27-e29.

10. P García-Pavía, JM Tomás, L Alonso-Pulpón. Late-onset angioedema due to an angiotensin converting enzyme inhibitor. Can J Cardiol 2007;23:315-6.

11. P Garcia-Pavia, P Aguiar-Souto, R Ocaranza. Effect of shear stress on plaque rupture. Can J Cardiol 2007; 23:396.

12. P Garcia-Pavia, J Segovia, J Molano, R Mora, F Kontny, K Erik-Berge, TP Leren, L Alonso-Pulpón. Miocardiopatía Hipertrófica de alto riesgo asociada a una nueva mutación en la Proteína C Fijadora de Miosina. Rev Esp Cardiol 2007;60:311-4.

13. J Escaned Barbosa, E Roig Minguell, FJ Chorro Gascó, E De Teresa Galván, M Jiménez Mena, E López de Sá y Areses, F Alfonso Manterola, LGómez Esmorís, F Martin Burrieza, MJ Salvador Taboada, LA Alonso-Pulpón Rivera, M Anguita Sánchez, E Asín Cardiel, X Bosch Genover, A Castro Beiras, V Cañadas Godoy, F Fernández Avilés, P García Pavía, RM Lidón Corbí, JL López Sendón, C Macaya Miguel, R Masía Martorel, N Murga Eizagaechevarría, J Ortega Marcos, C Permanyer Miralda, ESales González, J Sanchis Fores, G Sanz Romero, P Tornos Mas. The scope of cardiological competence in the new clinical settings. Spanish Society of Cardiology consensus document. Rev Esp Cardiol 2008;61:161-9.

14. Gomez-Bueno M, Segovia J, García-Pavía P, Barceló JM, Krsnik I, Sanchez-Turrion V, Salas C, Alonso-Pulpon L. Amiloidosis Cardiaca: la importancia del manejo multidisciplinario. Rev Esp Cardiol 2009;62:698-702.

15. Escaned J, Flores-Galaviz A, García-Pavía P, Segovia J, Jiménez J, Aragoncillo P, Salas C, Alfonso F, Hernández R, Angiolillo DJ, Jimenez-Quevedo, Bañuelos C, Alonso-Pulpón L, Macaya C. Assessesment of microcirculatory remodeling with intracoronary flow velocity and pressure measurements. Validation with endomyocardial sampling in cardiac allografts. Circulation 2009;120:1561-8.

16. García-Pavía P, Segovia J, Gómez-Bueno M, Alonso-Pulpón LA. Miocardopatías. Concepto. Tipos. Clasificación. Medicine 2009;10:2815-9.

17. Pérez Pereira E, Sufrate Sorzano E, García-Pavía P, Alonso-Pulpón LA. Miocardopatía Dilatada. Medicine 2009;10:2820-4.

18. Pérez Pereira E, Sufrate Sorzano E, García-Pavía P, Alonso-Pulpón LA. Miocardopatía Restrictiva. Medicine 2009;10:2825-30.

19. Sufrate Sorzano E, Pérez Pereira E, García-Pavía P, Alonso-Pulpón LA. Miocardopatía Hipertrófica. Medicine 2009;10:2831-7.

20. García-Pavía P, Gómez-Bueno M, Segovia J, Alonso-Pulpón LA. Trasplante Cardiaco. Medicine 2009;10:2838-42.

21. García-Pavía P, Sufrate Sorzano E, Gómez-Bueno M, Alonso-Pulpón LA. Manejo general y extrahospitalario del paciente con miocardiopatías y con trasplante cardiaco. Medicine 2009;10:2843-9.

22. Pérez Pereira E, Sufrate Sorzano E, García-Pavía P, Alonso-Pulpón LA. Indicaciones de biopsia cardiaca. Medicine 2009;10:2851-3.

23. Sufrate Sorzano E, Pérez Pereira E, García-Pavía P, Alonso-Pulpón LA. Estudio en familiares de pacientes con miocardiopatías. Medicine 2009;10:2854-6.

24. Sufrate Sorzano E, Pérez Pereira E, García-Pavía P, Alonso-Pulpón LA. Tratamiento de la obstrucción al tracto de salida del ventrículo izquierdo en la Miocardopatía Hipertrófica. Medicine 2009;10:2857-9.

25. García-Pavía P, Nombela Franco L, Segovia J, Alonso-Pulpón LA. Indicaciones del Trasplante Cardiaco. Medicine 2009;10:2860-1.

26. García-Pavía P, Gómez-Bueno M, Segovia J, Alonso-Pulpón LA. Varón de 52 años con dolor abdominal recurrente. Medicine 2009;10:2863e1-e5.

27. P García-Pavía, J Goicolea Ruigómez, JR López-Mínguez, P Fresneda Roldán, JM Nogales Asensio, JR Domínguez, J Segovia, L Alonso-Pulpón. Tratamiento endovascular de complicaciones tardías tras la reparación quirúrgica de la coartación aórtica. Rev Esp Cardiol 2010;63:473-7.

28. Segovia J, Gomez-Bueno M, Garcia-Pavia P, Cosio DG, Alonso-Pulpon L How could I treat? The Invited Experts' opinion. Eurointervention 2010;5:863-4.

29. P García-Pavía, P Avellana, B Bornstein, D Heine-Suñer, M Cobo-Marcos M Gómez-Bueno, J Segovia, L Alonso-Pulpón. Abordaje familiar en la amiloidosis cardiaca hereditaria por transtiretina. Rev Esp Cardiol 2011;64:523-6.

30. P García-Pavía, MT Tomé-Esteban, C Rapezzi. Amyloidosis. Also a cardiac disease. Rev Esp Cardiol 2011;64:797-808.

31. G Quarta, A Muir, A Pantazis, P Syrris, K Gehmlich, P Garcia-Pavia, D Ward, S Sen-Chowdhry, PM Elliott, WJ McKenna. Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria. Circulation 2011;123:2701-9.

32. Segovia J, Cosio MD, Barcelo J, Bueno MG, Pavia PG, Burgos R, Serrano-Fiz S, Garcia-Montero C, Castedo E, Ugarte J, Alonso-Pulpon L. RADIAL: a novel primary graft failure risk score in heart transplantation. J Heart Lung Transp 2011;30:644-51.

33. Avellana P, Segovia J, Sufrate E, Gómez-Bueno M, García-Cosío Carmena MD, García-Pavía P, Gutiérrez Landaluce C, Pérez Pereira E, Alonso-Pulpón L. Efectos a largo plazo (cinco años) de bosentán en pacientes con hipertensión arterial pulmonar. Rev Esp Cardiol 2011;64:667-73.

34. P Garcia-Pavia, P Syrris, C Salas, A Evans, JG Mirelis, M Cobo-Marcos, C Vilches, B Bornstein, J Segovia, L Alonso-Pulpon, PM Elliott. Desmosomal protein gene mutations in patients with idiopathic dilated cardiomyopathy undergoing cardiac transplantation: A clinicopathological study. Heart 2011;97:1744-52.

35. P Garcia-Pavia, ME Vázquez, J Segovia, C Salas, P Avellana, M Gómez-Bueno, C Vilches, ME Gallardo, R Garesse, J Molano, B Bornstein, L Alonso-Pulpon. Genetic basis of end-stage Hypertrophic Cardiomyopathy. Eur J Heart Fail 2011;13:1193-201.

36. AM Alonso Gómez, J Comín, X Borrás, S del Castillo, A E González, P Mazón, L Monserrat, A Pijuan, A Salvador Sanz, M Anguita, A Cequier, A Fernández-Ortiz, M Pan, F Worner, C Alonso, A Bardají, M Cobo, P García-Pavía, J González Gostello, JM Oliver, M Pedreira, JM Serrano, M Subirana, P Tornos. Comments on the ESC Guidelines on the management of cardiovascular diseases during pregnancy. A critical vision of Spanish cardiology. Rev Esp Cardiol 2012;65:113-8.

37. Gallardo ME, García-Pavía P, Chamorro R, Vázquez ME, Gómez-Bueno M, Millán I, Almoguera B, Domingo V, Segovia J, Vilches C, Alonso-Pulpón L, Garesse R, Bornstein B. Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients. Eur Heart J 2012;33:346-53.

38. L Alonso-Pulpón, J Segovia, M Gómez-Bueno, P García-Pavía. Cardiac transplantation: organizational aspects and current trends in immunosuppression. A view from Spain. Heart 2012;98:878-89.

39. JJ Arredondo, ME Gallardo, P Garcia-Pavia, V Domingo, B Bretona, MT Garcia-Silva, MJ Sedano, MA Martin, J Arenas, M Cervera, R Garesse, B Bornstein. Mitochondrial tRNA valine as a recurrent target for mutations involved in mitochondrial cardiomyopathies. Mitochondrion 2012;12:357-62.

40. de Haro-del Moral FJ, Sánchez-Lajusticia A, Gómez-Bueno M, García-Pavía P, Salas-Antón C, Segovia-Cubero J. Role of cardiac scintigraphy with 99m-Tc-DPD for differentiation of cardiac amyloidosis subtype.. Rev Esp Cardiol 2012;65:440-5.

41. Halperin I, Aller J, Varela C, Mora M, Abad A, Doltra A, Estrella Santos A, Batista E, Garcia-Pavia P, Sitges M, Mirelis JG, Lucas T, Puig-Domingo M. No clinical significant valvular regurgitation in long term cabergoline treatment for prolactinoma. Clin Endocrinol (Oxf) 2012;77:275-80.

42. Campuzano O, Alcalde M, Berne P, Castro V, Guzzo G, Iglesias A, Alonso-Pulpon L, Garcia-Pavia P, Brugada J, Brugada R. Genetic Testing of Candidate Genes in arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Eur J Med Genet 2012; 55:225-34.

43. G Luxán, JF Casanova, B Martínez-Poveda, D McGrogan, A Gonzalez-Rajal, B Prados, G D'Amato, D Dobarro, C Torroja, F Martinez, JL Izquierdo-García, Y Kong, G Pizarro, B Ibañez-Cabeza, C Medrano, P García-Pavía, JR Gimeno, L Montserrat, LJ Jiménez-Borreguero, JL de la Pompa. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med 2013;19:193-201.

44. F Domínguez, M Cobo-Marcos, G Guzzo, MA Cavero, JG Mirelis, L Alonso-Pulpon, P Garcia-Pavia. Erysipelas and acute myocarditis. An unusual combination. Can J Cardiol 2013;29:1138e3-5.

45. Campuzano O, Alcalde M, Allegue C, Iglesias A, Garcia-Pavia P, Partemi S, Oliva A, Pascali VL, Berne P, Sarquella-Brugada G, Brugada J, Brugada P, Brugada R. Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy. J Med Genet 2013;50:280-9.

46. Flaquer A, Baumbach C, Piñero E, García Algas F, de la Fuente Sanchez MA, Rosell J, Toquero J, Alonso-Pulpon L, Garcia-Pavia P, Strauch K, Heine-Suñer D. Genome-wide linkage analysis of congenital heart defects using MOD score analysis identifies two novel loci. BMC Genet. 2013;14(1):44.

47. Molina-Navarro MM, Roselló-Lletí E, Tarazón E, Ortega-Gutiérrez A, Sánchez-Izquierdo D, Lago F, García-Pavía P, Salvador A, Montero JA, Portolés M, Rivera M. Heart failure entails significant changes in human nucleocytoplasmic transport gene expression. Int J Cardiol. 2013;168:2837-43.

48. Cobo-Marcos M, Cuenca S, Gamez Martinez JM, Bornstein B, Ripoll T, Garcia-Pavia P. Usefulness of genetic testing in Hypertrophic cardiomyopathy in real clinical practice. Rev Esp Cardiol 2013; 66:746-747.

49. Garcia-Pavia P, Cobo-Marcos M, Guzzo-Merello G, Gomez-Bueno M, Bornstein B, Lara-Pezzi E, Segovia J, Alonso-Pulpon L. Genetics in Dilated Cardiomyopathy. Biomark Med 2013;7:517-33.

50. Lara-Pezzi E, Gomez-Salinero J, Gatto A, Garcia-Pavia P. The alternative heart: impact of alternative splicing in heart disease. Journal of Cardiovascular Translational Research 2013;6:945-55.

51. Villar P, Breton B, García-Pavía P, Gonzalez-Paramos C, Blazquez A, Gomez-Bueno M, García-Silva T, García-Consuegra I, Martin M, Garesse, R, Bornstein B, Gallardo ME. Cardiac dysfunction in mitochondrial diseases: A clinical and molecular study. Circ J 2013;77:2799-806.

52. Molina-Navarro MM, Roselló-Lleti E, Ortega A, Tarazon E, Otero M, Martinez-Doltz L, Lago F, Gonzalez-Juanatey JR, España F, Garcia-Pavia P, Montero JA, Portoles M, Rivera M. Differential gene expression of cardiac ion channels in human dilated cardiomyopathy. Plos One 2013 8(12):e79792.

53. Ramos A, García-Pavía P, Orden B, Cobo M, Sánchez-Castilla M, Sánchez-Romero I, Múñez E, Marín M, García-Montero C. Gonococcal endocarditis: a case report and review of the literature. Infection. 2014;42:425-8.

54. López-Olañeta MM, Villalba M, Gómez-Salinero JM, Jiménez-Borreguero LJ, Breckenridge R, Ortiz-Sánchez P, García-Pavía P, Ibáñez B, Lara-Pezzi E. Induction of the calcineurin variant CnAβ1 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularization. Cardiovasc Res. 2014;102:396-406.

55. Guzzo-Merello G, Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Alcoholic Cardiomyopathy. World J Cardiology 2014;6:771-81.

56. Alcalde M, Campuzano O, Berne P, Garcia-Pavia P, Doltra A, Arbelo E, Sarquella-Brugada G, Iglesias A, Alonso-Pulpon L, Brugada J, Brugada R. Stop gain mutations are assossiated with a later age of onset of Arrhythmogenic Right Ventricular Cardiomyopathy. Plos One 2014 Jun 26;9(6):e100560. doi: 10.1371/journal.pone.0100560. eCollection 2014.

57. Cobo-Marcos M, Gallego-Delgado M, Garcia-Pavia P. Aplicación práctica de la genética en el manejo de las miocardiopatías. Cardiocore 2014;49:52-8.

58. Ramos Martínez A, García Montero C, Sánchez Romero I, García Pavía P. Aortic tube infections due to Propionibacterium acnes. Rev Clin Esp. 2014;214:544-5.

59. Garcia-Pavia P, de la Pompa JL. Left Ventricular Non-Compaction: A genetic cardiomyopathy looking for diagnostic criteria. J Am Coll Cardiol 2014;64:1981-1983.

60. Guzzo-Merello G, Segovia J, Dominguez F, Cobo-Marcos M, Gomez-Bueno M, Avellana P, Millan I, Alonso-Pulpon L, Garcia-Pavia P. Natural history and risk factors in Alcoholic Cardiomyopathy. JACC Heart Failure 2015;3:78-86.

61. Garcia-Pavia P. ECG, May 2015. Rev Esp Cardiol 2015;68:439.

62. Mirelis JG, Garcia-Pavia P, Cavero MA, González-López E, Echavarria-Pinto M, Pastrana M, Segovia J, Oteo JF, Alonso-Pulpón L, Escaned J. Magnetic Resonance for Noninvasive Detection of Microcirculatory Disease Associated to Allograft Vasculopathy: Intracoronary Measurements Validation. Rev Esp Cardiol 2015 68:571-8.

63. Gallego-Delgado M, Cobo-Marcos M, Bornstein B, Hernández-Laín A, Alonso-Pulpón L, García-Pavía P. Mitochondrial Cardiomyopathies associated to the m.3243A>G mutation in MT-TL1 Gene: two sides from same coin. Rev Esp Cardiol 2015;68:153-5.

64. Zegri Reiriz I, Mingo S, Garcia-Pavia P. Endophtalmitis and a heart murmur. Rev Esp Cardiol 2015;68:804.

65. Krsnik I, Cabero M, Morillo D, Segovia J, Garcia-Pavia P, Gomez-Bueno M, Salas C. Amiloidosis AL: experiencia de un hospital terciario 2005-2013. Rev Clin Esp 2015;215:1-8.

66. Garcia-Pavia P, et al. Comments on the 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy. A Critical Vision of Spanish Cardiology. Rev Esp Cardiol 2015;68:4-9.

67. Garcia-Pavia P, Muñoz-Beamud F, Casanovas C en representación del Grupo Español para el estudio y tratamiento de la Polineuropatia Amiloidótica Familiar (GET-PAF). Recommendations regarding diagnosis and treatment of transthyretin familial amyloid polyneuropathy. Med Clin (Barc) 2015;145:211-7

68. Gallego-Delgado M, Gonzalez-Lopez E, Garcia-Guereta L, Ortega-Molina, M, Gonzalez-Vioque E, Cobo-Marcos M, Alonso-Pulpon L, Garcia-Pavia P. Adverse clinical course and poor prognosis of hypertrophic cardiomyopathy due to mutations in FHL1. Int J Cardiol 2015; 191:194-7.
69.Aortic composite tube valve graft infection due to Streptococcus pneumonia. J Nuc Cardiol 2016;23:168-9.

70. Gonzalez-Lopez E, Gallego-Delgado M, Guzzo-Merello G, de Haro FJ, Cobo-Marcos M, Bornstein B, Salas C, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J 2015; 36: 2585-94.

71. Guzzo-Merello G, Dominguez F, Gonzalez-Lopez E, Cobo-Marcos M, Gomez-Bueno M, Millan I, Fernandez-Lozano I, Segovia J, Alonso-Pulpon L, Garcia-Pavia P. Ventricular arrhythmias in Alcoholic cardiomyopathy. Int J Cardiol 2015;199:99-105.

72. Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Heart Fail. 2015 17:837-45.

73. Robles C, Gallego-Delgado M, Castro-Urda V, Muñoz-Esparza C, González-Vioque E, García-Pavía P. Familial Paralysis of the Atrium Due to a Mutation in SCN5A. Rev Esp Cardiol (Engl Ed). 2015;68:904-6.

74. Calvete O, Martinez P, Garcia-Pavia P, Benitez-Buelga C, Paumard-Hernández B, Fernandez V, Dominguez F, Salas C, Romero-Laorden N, Garcia-Donas J, Carrillo J, Perona R, Triviño JC, Andrés R, Cano JM, Rivera B, Alonso-Pulpon L, Setien F, Esteller M, Rodriguez-Perales S, Bougeard G, Frebourg T, Urioste M, Blasco MA, Benítez J. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families. Nat Commun. 2015 Sep 25;6:8383. doi: 10.1038/ncomms9383.

75. de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E; GAMES Study Group. Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century: A Systematic Review of 111 Cases (2000-2013). Medicine (Baltimore).
2015;94(39):e1562. doi: 10.1097/MD.0000000000001562

76. Li YR, van Setten J, Verma SS, Lu Y, Holmes MV, Gao H, Lek M, Nair N, Chandrupatla H, Chang B, Karczewski KJ, Wong C, Mohebnasab M, Mukhtar E, Phillips R, Tragante V, Hou C, Steel L, Lee T, Garifallou J, Guettouche T, Cao H, Guan W, Himes A, van Houten J, Pasquier A, Yu R, Carrigan E, Miller MB, Schladt D, Akdere A, Gonzalez A, Llyod KM, McGinn D, Gangasani A, Michaud Z, Colasacco A, Snyder J, Thomas K, Wang T, Wu B, Alzahrani AJ, Al-Ali AK, Al-Muhanna FA, Al-Rubaish AM, Al-Mueilo S, Monos DS, Murphy B, Olthoff KM, Wijmenga C, Webster T, Kamoun M, Balasubramanian S, Lanktree MB, Oetting WS, Garcia-Pavia P, MacArthur DG, de Bakker PI, Hakonarson H, Birdwell KA, Jacobson PA, Ritchie MD, Asselbergs FW, Israni AK, Shaked A, Keating BJ. Concept and design of a genome-wide association genotyping array tailored for transplantation-specific studies. Genome Med. 2015;7:90. doi: 10.1186/s13073-015-0211-x.

77. Claes GR, van Tienen FH, Lindsey P, Krapels IP, Helderman-van den Enden AT, Hoos MB, Barrois YE, Janssen JW, Paulussen AD, Sels JE, Kuijpers SH, van Tintelen JP, van den Berg MP, Heesen WF, Garcia-Pavia P, Perrot A, Christiaans I, Salemink S, Marcelis CL, Smeets HJ, Brunner HG, Volders PG, van den Wijngaard A. Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers. Eur Heart J. 2016;37:1815-22.

78. Zhang KK, Xiang M, Zhou L, Liu J, Curry N, Heine Suñer D, Garcia-Pavia P, Zhang X, Wang Q, Xie L. Gene-network and familial analyses uncover a gene network involving Tbx5/Osr1/Pcsk6 interaction in the second heart field for atrial septation. Hum Mol Genet. 2016; 25:1140-51.

79. Dominguez F, Kühl U, Pieske B, Garcia-Pavia P, Tschöpe C. Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy. Rev Esp Cardiol (Engl Ed). 2016 69:178-87.

80. Barriales-Villa R, Gimeno-Blanes JR, Zorio-Grima E, Ripoll-Vera T, Evangelista-Masip A, Moya-Mitjans A, Serratosa-Fernández L, Albert-Brotons DC, García-Pinilla JM, García-Pavía P. Plan of Action for Inherited Cardiovascular Diseases: Synthesis of Recommendations and Action Algorithms. Rev Esp Cardiol (Engl Ed). 2016;69:300-9

81. Cuenca S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, Salas C, Gomez-Diaz I, Padron-Barthe L, Grillo JJ, Vilches C, Segovia J, Pascual-Figal D, Lara-Pezzi E, Monserrat L, Alonso-Pulpon L, Garcia-Pavia P. Genetic basis of familial dilated cardiomyopathy undergoing heart transplantation. J Heart Lung Transplant 2016;35:625-35

82. Idiazabal U, García-Pavía P, Azcárate PM, Idoate F, Mercado MR. Amiloidosis cardiaca por transtiretina: la gammagrafía mostró el camino. Rev Colomb Cardiol. 2016;23:71.e1-71.e5.

83. Gallego-Delgado M, Gonzalez-Lopez E, Muñoz-Beamud F, Buades J, Galán L, Muñoz-Blanco JL, Sánchez-González J, Ibáñez B, Mirelis JG, García- Pavía P. Cardiac Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-Familial Amyloidosis. Rev Esp Cardiol 2016;69:923-930.

84. Ramos A, García-Montero C, Moreno A, Muñoz P, Ruiz-Morales J, Sánchez-Espín G, Porras C, Sousa D, Castelo L, Fariñas C, Gutiérrez F, Reguera JM, Plata A, Bouza E, Antorrena I, Alarcón A, Pericás JM, Gurguí M, Rodríguez-Abella H, Goenaga MA, Oteo JA, García-Pavía P. Endocarditis in patients with Ascending Aortic Prosthetic Graft: A Case Series from a National Multicenter Registry. Eur J Cardiothorac Surg 2016;50:1149-1157.

85. M. Gallego-Delgado, JF Delgado, V Brossa-Loidi, J Palomo, R Marzoa-Rivas,, F Perez-Villa, J Salazar-Mendiguchía, MJ Ruiz-Cano, E Gonzalez-Lopez, L Padron-Barthe, B Bornstein, L Alonso-Pulpon, P Garcia-Pavia. Idiopathic restrictive cardiomyopathy is primarily a genetic disease. J Am Coll Cardiol 2016;67:3021-3.

86. Sayago I, Krsnik I, Gómez-Bueno M, García-Pavía P, Jaramillo N, Salas C, Mingo S, Oteo JF, Alonso-Pulpón L, Segovia J. Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis. J Heart Lung Transplant 2016;35:995-1002

87. Dominguez F, Ramos A, Bouza E, Muñoz P, Valerio MC, Fariñas MC, de Berrazueta JR, Zarauza J, Pericás Pulido JM, Paré JC, de Alarcón A, Sousa D, Rodriguez Bailón I, Montejo-Baranda M, Noureddine M, García Vázquez E, Garcia-Pavia P. Infective endocarditis in hypertrophic cardiomyopathy: A multicenter, prospective, cohort study. Medicine (Baltimore) 2016 Jun;95(26):e4008. doi: 10.1097/MD.0000000000004008.

88. Gómez-Salinero JM, López-Olañeta MM, Ortiz-Sánchez P, Larrasa-Alonso J, Gatto A, Felkin LE, Barton PJ, Navarro-Lérida I, Ángel Del Pozo M, García-Pavía P, Sundararaman B, Giovinazo G, Yeo GW, Lara-Pezzi E. The Calcineurin Variant CnAβ1 Controls Mouse Embryonic Stem Cell Differentiation by Directing mTORC2 Membrane Localization and Activation. Cell Chem Biol 2016;23:1372-1382.

89. Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators. Predictors of atrial fibrillation in hypertrophic cardiomyopathy. Heart 2017; 103:672-678.

90. Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, Padrón-Barthe L, Duro-Aguado I, Jiménez-Jáimez J, Hidalgo- Olivares VM, García-Campo E, Lanzillo C, Suárez-Mier MP, Yonath H, Marcos-Alonso S, Ochoa JP, Santomé JL, García-Giustiniani D, Rodríguez-Garrido JL, Domínguez F, Merlo M, Palomino J, Peña ML, Trujillo JP, Martín-Vila A, Stolfo D, Molina P, Lara-Pezzi E, Calvo-Iglesias FE, Nof E, Calò L, Barriales-Villa R, Gimeno-Blanes JR, Arad M, García-Pavía P, Monserrat L. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol. 2016;68:2440-2451.

91. Quarta G, Coppini R, Lambiase P, García-Pavía P, Calabrese A, Iorio AM, Maurizi N, Iascone M, Gavazzi A, Olivotto I, Senni M. Reversible dilated cardiomyopathy: into de thaumaturgy of the heart. Part 1. Cardiogenetics 2016; 6:5861.

92. Quarta G, Coppini R, Lambiase P, García-Pavía P, Calabrese A, Iorio AM, Maurizi N, Iascone M, Gavazzi A, Olivotto I, Senni M. Reversible dilated cardiomyopathy: into de thaumaturgy of the heart. Part 2. Cardiogenetics 2016; 6:5862 doi:10.4081/cardiogenetics.2016.5862

93. Reisin R, Perrin A, García-Pavía P. Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pract. 2017;71. doi: 10.1111/ijcp.12914.

94. Restrepo-Cordoba MA, Campuzano O, Ripoll-Vera T, Cobo-Marcos M, Mademont-Soler I, Gámez JM, Dominguez F, Gonzalez-Lopez E, Padron-Barthe L Lara-Pezzi E, Alonso-Pulpon L, Brugada R, Garcia-Pavia P. Usefulness of genetic testing in hypertrophic cardiomyopathy. An analysis using real-world data. J Cardiovasc Trans Res 2017;10:35-46.

95. González-López E, Gagliardi C, Dominguez F, Quarta CC, de Haro-del Moral FJ, Milandri A, Salas C, Cinelli M, Cobo-Marcos M, Lorenzini M, Lara- Pezzi E, Foffi S, Alonso-Pulpon L, Rapezzi C, Garcia-Pavia P. Clinical characteristics of wild-type transthyretin cardiac amyloidosis – Disproving myths. Eur Heart J 2017;38:1895–1904.

96. Mirelis JG, Sánchez-González J, Zorio E, Ripoll-Vera T, Salguero-Bodes R, Filgueiras-Rama D, González-López E, Gallego-Delgado M, Fernández-Jiménez R, Soleto MJ, Núñez J, Pizarro G, Sanz J, Fuster V, García-Pavía P, Ibáñez B. Myocardial Extracellular Volume Is not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2017 Mar 21.

97. Ramos-Martínez A, Roque F, Fariñas MC, Muñoz P, Verde E, Cuerpo GP, de Alarcón A, Lepe JA, Miró JM, Plata A, Goenaga MÁ, García-Rosado D, Martínez-Monzonis A, de la Torre J, García-Pavía P. Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry. Int J Cardiol. 2017 Apr 29. pii: S0167-5273(16)34061-X. doi: 10.1016/j.ijcard.2017.04.086. [Epub ahead of print]

98. de Miguel C, Llorente L, de Haro-Del Moral FJ, García-Pavía P, González-López E, Segovia J, Krsnik I. Myocardial uptake of 99mTc-DPD in patients with AL amyloidosis. Amyloid. 2017 Mar;24(sup1):48-49.

99. Villalba-Orero M, López-Olañeta MM, González-López E, Padrón-Barthe L, Gómez-Salinero JM, García-Prieto J, Wai T, García-Pavía P, Ibáñez B, Jiménez-Borreguero LJ, Lara-Pezzi E. Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice. Cardiovasc Res. 2017 May 4. doi: 10.1093/cvr/cvx090. [Epub ahead of print]

100. Yardeni M, Weisman O, Mandel H, Weinberger R, Quarta G, Salazar-Mendiguchía J, Garcia-Pavia P, Lobato-Rodríguez MJ, Simon LF, Dov F, Arad M, Gothelf D. Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation). Am J Med Genet A. 2017 Jun 19. doi: 10.1002/ajmg.a.38320. [Epub ahead of print]

101. Villalba-Orero M, Sánchez-Elexpuru G, López-Olañeta M, Campuzano O, Bello-Arroyo E, García-Pavía P, Serratosa JM, Brugada R, Sánchez MP, Lara-Pezzi E. Lafora Disease Is an Inherited Metabolic Cardiomyopathy. J Am Coll Cardiol. 2017 ;69:3007-3009.

102. Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.Eur Heart J. 2017 Jun 26. doi: 10.1093/eurheartj/ehx321

103. Padrón-Barthe L, Domínguez F, Garcia-Pavia P*, Lara-Pezzi E*. Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics. Basic Res Cardiol. 2017;112:50. *Co-autores de correspondencia.

104. Mademont-Soler I, Mates J, Yotti R, Espinosa MA, Pérez-Serra A, Fernandez-Avila AI, Coll M, Méndez I, Iglesias A, Del Olmo B, Riuró H, Cuenca S, Allegue C, Campuzano O, Picó F, Ferrer-Costa C, Álvarez P, Castillo S, Garcia-Pavia P, Gonzalez-Lopez E, Padron-Barthe L, Díaz de Bustamante A, Darnaude MT, González-Hevia JI, Brugada J, Fernandez-Aviles F, Brugada R. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy. PLoS One. 2017 Aug 3;12(8):e0181465.

105. Gastelurrutia P, Gálvez-Montón C, Cámara ML, Bustamante-Munguira J, García-Pavia P, Avanzas P, Alberto San Román J, Pascual-Figal D, Teresa E, Crespo-Leiro MG, Manito N, Núñez J, Fernández-Avilés F, Caballero Á, Teis A, Lupón J, Brugada R, Martín C, Silva J, Revilla-Orodea A, Cánovas SJ, Melero JM, Cuenca-Castillo JJ, Gonzalez-Pinto A, Bayes-Genis A. Rationale and design of a multicentre, prospective, randomised, controlled clinical trial to evaluate the efficacy of the adipose graft transposition procedure in patients with a myocardial scar: the AGTP II trial. BMJ Open. 2017 Aug 4;7(8):e017187. doi: 10.1136/bmjopen-2017-017187.

106. Dominguez F, Climent V, Zorio E, Ripoll-Vera T, Salazar-Mendiguchía J, García-Pinilla JM, Urbano-Moral JA, Fernández-Fernández X, Lopez-Cuenca D, Ajo-Ferrer R, Sanz-Sanchez J, Gomez-Perez Y, López-Garrido MA, Barriales-Villa R, Gimeno JR, Garcia-Pavia P. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation. Int J Cardiol. 2017;248:232-238

107. Villalba-Orero M, López-Olañeta M, García-Pavía P, Lara-Pezzi E. Systolic Dysfunction in Infarcted Mice Does Not Necessarily Lead to Heart Failure: Need to Refine Preclinical Model. J Cardiovasc Transl Res. 2017 Aug 15. doi: 10.1007/s12265-017-9765-x. [Epub ahead of print]

108. Amor-Salamanca A, Castillo S, Gonzalez-Vioque E, Dominguez F, Quintana L, Lluís-Ganella C, Escudier JM, Ortega J, Lara-Pezzi E, Alonso-Pulpon L, Garcia-Pavia P. Genetically Confirmed Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome. J Am Coll Cardiol. 2017;70:1732-40.

109. González-López E, López-Sainz Á, Garcia-Pavia P. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope. Rev Esp Cardiol (Engl Ed). 2017;70:991-1004.

110. Calvete O, Garcia-Pavia P, Domínguez F, Bougeard G, Kunze K, Braeuninger A, Teule A, Lasa A, Ramón Y Cajal T, Llort G, Fernández V, Lázaro C, Urioste M, Benitez J. The wide spectrum of POT1 gene variants correlates with multiple cancer types. Eur J Hum Genet. 2017;25:1278-1281.

111. Varga ZV, Pipicz M, Baán JA, Baranyai T, Koncsos G, Leszek P, Kuśmierczyk M, Sánchez-Cabo F, García-Pavía P, Brenner GJ, Giricz Z, Csont T, Mendler L, Lara-Pezzi E, Pacher P, Ferdinandy P. Alternative Splicing of NOX4 in the Failing Human Heart. Front Physiol. 2017 Nov 22;8:935. doi: 10.3389/fphys.2017.00935. eCollection 2017.

112. Barbeito-Caamaño C, Cao-Vilariño M, Mosquera-Reboredo J, García-Pavía P, Monserrat-Iglesias L, Barriales-Villa R. The p.Arg118Cys Variant in the GLA Gene Does not Cause Fabry Disease. More Evidence. Rev Esp Cardiol (Engl Ed). 2018; 71(10):871-873.

113. O'Mahony C, Jichi F, Ommen SR, Christiaans I, Arbustini E, Garcia-Pavia P, Cecchi F, Olivotto I, Kitaoka H, Gotsman I, Carr-White G, Mogensen J, Antoniades L, Mohiddin S, Maurer MS, Tang HC, Geske JB, Siontis KC, Mahmoud K, Vermeer A, Wilde A, Favalli V, Guttmann O, Gallego-Delgado M, Dominguez F, Tanini I, Kubo T, Keren A, Bueser T, Waters S, Issa IF, Malcolmson J, Burns T, Sekhri N, Hoeger CW, Omar RZ, Elliott PM. An International External Validation Study of the 2014 European Society of Cardiology Guideline on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (Evidence from HCM). Circulation 2018;137:1015-23.

114. Dominguez F, Gonzalez-Lopez E, Padron-Barthe L, Cavero MA, Garcia-Pavia P. The role of echocardiography in the diagnosis and management of hypertrophic cardiomyopathy. Heart 2018; 104:261-273.

115. Padrón-Barthe L, Villalba-Orero M, Gómez-Salinero JM, Acín-Pérez R, Cogliati S, López-Olañeta M, Ortiz-Sánchez P, Bonzón-Kulichenko E, Vázquez J, García-Pavía P, Rosenthal N, Enríquez JA, Lara-Pezzi E. Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function. J Am Coll Cardiol 2018;71:654-67.

116. Mates J, Mademont-Soler I, Del Olmo B, Ferrer-Costa C, Coll M, Pérez-Serra A, Picó F, Allegue C, Fernandez-Falgueras A, Álvarez P, Yotti R, Espinosa MA, Sarquella-Brugada G, Cesar S, Carro E, Brugada J, Arbelo E, Garcia-Pavia P, Borregan M, Tizzano E, López-Granados A, Mazuelos F, Díaz de Bustamante A, Darnaude MT, González-Hevia JI, Díaz-Flores F, Trujillo F, Iglesias A, Fernandez-Aviles F, Campuzano O, Brugada R. Role of copy number variants in sudden cardiac death and related diseases: genetic analysis and translation into clinical practice. Eur J Hum Genet. 2018;26:1014-1025.

117. Ware JS, Amor-Salamanca A, Tayal U, Govind R, Serrano I, Salazar-Mendiguchía J, García-Pinilla JM, Pascual-Figal D, Nuñez J, Guzzo-Merello G, Gonzalez-Vioque E, Bardaji A, Manito N, López-Garrido MA, Padron-Barthe L, Edwards E, Whiffin N, Walsh R, Buchan RJ, Midwinter W, Wilk A, Prasad S, Pantazis A, O’Regan DP, Alonso-Pulpon L, Cook SA, Lara-Pezzi E, Barton P, Garcia-Pavia P. A genetic etiology for alcohol-induced cardiac toxicity. J Am Coll Cardiol. 2018;71:2293-302.

118. Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, Falces C, Gonzalez Rico C, Kortajarena Urkola X, Lepe JA, Rodriguez Alvarez R, Reguera Iglesias JM, Navas E, Dominguez F, Garcia-Pavia P. Infective endocarditis in bicuspid aortic valve and mitral valve prolapse. J Am Coll Cardiol. 2018;71:2731–40.

119. Amor-Salamanca A, Guzzo-Merello G, González-López E, Domínguez F, Restrepo-Córdoba A, Cobo-Marcos M, Gómez-Bueno M, Segovia-Cubero J, Alonso-Pulpón L, García-Pavía P. Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2018;71:612-619

120. Mohamed-Salem L, Santos-Mateo JJ, Sanchez-Serna J, Hernández-Vicente Á, Reyes-Marle R, Castellón Sánchez MI, Claver-Valderas MA, Gonzalez-Vioque E, Haro-Del Moral FJ, García-Pavía P, Pascual-Figal DA. Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population. Int J Cardiol. 2018;270:192-196

121. Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study. J Cardiovasc Pharmacol Ther. 2018;23:543-50.

122. Domínguez F, Cuenca S, Bilińska Z, Toro R, Villard E, Barriales-Villa R, Ochoa JP, Asselbergs F, Sammani A, Franaszczyk M, Akhtar M, Coronado-Albi MJ, Rangel-Sousa D, Rodriguez-Palomares JF, Jiménez-Jáimez J, Garcia-Pinilla JM, Ripoll-Vera T, Mogollón-Jiménez MV, Fontalba-Romero A, Garcia-Medina D, Palomino-Doza J, de Gonzalo-Calvo D, Cicerchia M, Salazar-Mendiguchia J, Salas C, Pankuweit S, Hey TM, Mogensen J, Barton PJ, Charron P, Elliott P, Garcia-Pavia P; Dilated Cardiomyopathy Due to BLC2- Associated Athanogene 3 (BAG3) Mutations. J Am Coll Cardiol. 2018;72:2471-2481.

123. Ochoa JP, Sabater-Molina M, García-Pinilla JM, Mogensen J, Restrepo-Córdoba A, Palomino-Doza J, Villacorta E, Martinez-Moreno M, Ramos-Maqueda J, Zorio E, Peña-Peña ML, García-Granja PE, Rodríguez-Palomares JF, Cárdenas-Reyes IJ, de la Torre-Carpente MM, Bautista-Pavés A, Akhtar MM, Cicerchia MN, Bilbao-Quesada R, Mogollón-Jimenez MV, Salazar-Mendiguchía J, Mesa Latorre JM, Arnaez B, Olavarri-Miguel I, Fuentes-Cañamero ME, Lamounier A Jr, Pérez Ruiz JM, Climent-Payá V, Pérez-Sanchez I, Trujillo-Quintero JP, Lopes LR, Repáraz-Andrade A, Marín-Iglesias R, Rodriguez-Vilela A, Sandín-Fuentes M, Garrote JA, Cortel-Fuster A, Lopez-Garrido M, Fontalba-Romero A, Ripoll-Vera T, Llano-Rivas I, Fernandez-Fernandez X, Isidoro-García M, Garcia-Giustiniani D, Barriales-Villa R, Ortiz-Genga M, García-Pavía P, Elliott PM, Gimeno JR, Monserrat L. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2018;72:2457-2467.

124. Zegri-Reiriz I, Cobo-Marcos M, Rodriguez-Alfonso B, Millán R, Dominguez F, Forteza A, Garcia-Pavia P, Ramos-Martinez A. Successful treatment of healthcare-associated Mycobacterium chimaera prosthetic infective endocarditis: the first Spanish case report. Eur Heart J Case Rep. 2018 Dec 6;2(4):yty142.

125. Dominguez F, Sanz-Sánchez J, García-Pavía P, Zorio E. Follow-up and prognosis of HCM. Glob Cardiol Sci Pract 2018(3):33.

126. López-Sainz Á, Salazar-Mendiguchía J, García-Álvarez A, Campuzano Larrea O, López-Garrido MÁ, García-Guereta L, Fuentes Cañamero ME, Climent Payá V, Peña-Peña ML, Zorio-Grima E, Jordá-Burgos P, Díez-López C, Brugada R, García-Pinilla JM, García-Pavía P. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry. Rev Esp Cardiol (Engl Ed). 2019;72:479-486

127. O'Mahony C, Akhtar MM, Anastasiou Z, Guttmann OP, Vriesendorp PA, Michels M, Magrì D, Autore C, Fernández A, Ochoa JP, Leong KMW, Varnava AM, Monserrat L, Anastasakis A, Garcia-Pavia P, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Omar RZ, Elliott PM. Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart 2019;105:623-631.

128. Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, Camacho Salas A, Casanova Rodríguez C, Cobo Esteban AM, Díaz Guardiola P, Fernández-Torrón R, Gallano Petit MP, García Pavía P, Gómez Gallego M, Gutiérrez Martínez AJ, Jericó I, Kapetanovic García S, López de Munaín Arregui A, Martorell L, Morís de la Tassa G, Moreno Zabaleta R, Muñoz-Blanco JL, Olivar Roldán J, Pascual Pascual SI, Peinado Peinado R, Pérez H, Poza Aldea JJ, Rabasa M, Ramos A, Rosado Bartolomé A, Rubio Pérez MÁ, Urtizberea JA, Zapata-Wainberg G, Gutiérrez-Rivas E. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease. Med Clin (Barc). 2019. pii: S0025- 7753(18)30731-0. doi: 10.1016/j.medcli.2018.10.028. [Epub ahead of print]

129. Domínguez F, Fuster V, Fernández-Alvira JM, Fernández-Friera L, López-Melgar B, Blanco-Rojo R, Fernández-Ortiz A, García-Pavía P, Sanz J, Mendiguren JM, Ibañez B, Bueno H, Lara-Pezzi E, Ordovás JM. Association of Sleep Duration and Quality With Subclinical Atherosclerosis. J Am Coll Cardiol. 2019;73:134-44.

130. Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, Camacho Salas A, Casanova Rodríguez C, Cobo AM, Díaz Guardiola P, Fernández-Torrón R, Gallano Petit MP, García Pavía P, Gómez Gallego M, Gutiérrez Martínez AJ, Jericó I, Kapetanovic García S, López de Munaín Arregui A, Martorell L, Morís de la Tassa G, Moreno Zabaleta R, Muñoz-Blanco JL, Olivar Roldán J, Pascual Pascual SI, Peinado Peinado R, Pérez H, Poza Aldea JJ, Rabasa M, Ramos A, Rosado Bartolomé A, Rubio Pérez MÁ, Urtizberea JA, Zapata-Wainberg G, Gutiérrez-Rivas E. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease. Neurologia. 2019 Apr 16. pii: S0213-4853(19)30019-2.

131. Martinez-Naharro A, Gonzalez-Lopez E, Corovic A, Mirelis JG, Baksi AJ, Moon JC, Garcia-Pavia P, Gillmore JD, Hawkins PN, Fontana M. High Prevalence of Intracardiac Thrombi in Cardiac Amyloidosis. J Am Coll Cardiol. 2019;73:1733-4.

132. Gomez-Salinero JM, Pavía PG, Lara-Pezzi E. CnAβ1 shifts cardiac metabolism. Aging (Albany NY). 2019 Jan 24;11(3):839-840.

133. Garcia-Pavia P*, Kim Y, Alejandra Restrepo-Cordoba M, Lunde IG, Wakimoto H, Smith AM, Toepfer CN, Getz K, Gorham J, Patel P, Ito K, Willcox JA, Arany Z, Li J, Owens AT, Govind R, Nuñez B, Mazaika E, Bayes-Genis A, Walsh R, Finkelman B, Lupon J, Whiffin N, Serrano I, Midwinter W, Wilk A, Bardaji A, Ingold N, Buchan R, Tayal U, Pascual-Figal DA, de Marvao A, Ahmad M, Garcia-Pinilla JM, Pantazis A, Dominguez F, Baksi AJ, O'Regan DP, Rosen SD, Prasad SK, Lara-Pezzi E, Provencio M, Lyon AR, Alonso-Pulpon L, Cook SA, DePalma SR, Barton PJR, Aplenc R, Seidman JG, Ky B, Ware JS, Seidman CE*. Genetic Variants Associated with Cancer Therapy-Induced Cardiomyopathy. Circulation 2019;140:31-41. *Co-corresponding authors

134. Ortiz-Sánchez P, Villalba-Orero M, López-Olañeta MM, Larrasa-Alonso J, Sanchez-Cabo F, Martí-Gómez C, Camafeita E, Gomez-Salinero JM, Ramos-Hernández L, Nielsen PJ, Vazquez J, Müller-McNicoll M, Garcia-Pavia P, Lara-Pezzi E. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction Related mRNAs and Severe Systolic Dysfunction. Circ Res. 2019;125:170-183.

135. Crotti L, Spazzolini C, Tester DJ, Ghidoni A, Baruteau AE, Beckmann BM, Behr ER, Bennett JS, Bezzina CR, Bhuiyan ZA, Celiker A, Cerrone M, Dagradi F, De Ferrari GM, Etheridge SP, Fatah M, Garcia-Pavia P, Al-Ghamdi S, Hamilton RM, Al-Hassnan ZN, Horie M, Jimenez-Jaimez J, Kanter RJ, Kaski JP, Kotta MC, Lahrouchi N, Makita N, Norrish G, Odland HH, Ohno S, Papagiannis J, Parati G, Sekarski N, Tveten K, Vatta M, Webster G, Wilde AAM, Wojciak J, George AL, Ackerman MJ, Schwartz PJ. Calmodulin mutations
and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry. Eur Heart J. 2019;40:2964-75.

136. López-Sainz Á, de Haro-Del Moral FJ, Dominguez F, Restrepo-Cordoba A, Amor-Salamanca A, Hernandez-Hernandez A, Ruiz-Guerrero L, Krsnik I, Cobo-Marcos M, Castro V, Toquero-Ramos J, Lara-Pezzi E, Fernandez-Lozano I, Alonso-Pulpon L, González-López E, Garcia-Pavia P. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders. Amyloid. 2019;26:156-163.

137. Zegri-Reiriz I, de Haro-Del Moral FJ, Dominguez F, Salas C, de la Cuadra P, Plaza A, Krsnik I, Gonzalez-Lopez E, Garcia-Pavia P. Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome. J Cardiovasc Transl Res. 2019;12:507-13.

138. López-Sainz Á, Climent V, Ripoll-Vera T, Espinosa MA, Barriales-Villa R, Navarro M, Limeres J, Domingo D, Kasper DC, Garcia-Pavia P. Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker. Orphanet J Rare Dis. 2019;14(1):170.

139. Witteles RM, Bokhari S, Damy T, Elliott PM, Falk RH, Fine NM, Gospodinova M, Obici L, Rapezzi C, Garcia-Pavia P. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019;7:709-716.

140. Norrish G, Ding T, Field E, Ziólkowska L, Olivotto I, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Kubuš P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Marrone C, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Castro FJ, Stuart G, Vignati G, Barriales-Villa R, Guereta LG, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Rasmussen TB, Calcagnino MM, Jones CB, De Wilde H, Toru-Kubo J, Felice T, Mogensen J, Mathur S, Reinhardt Z, O'Mahony C, Elliott PM, Omar RZ, Kaski JP. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids). JAMA Cardiol. 2019 Aug 14. doi: 10.1001/jamacardio.2019.2861. [Epub ahead of print]

141. Calvete O, Garcia-Pavia P, Domínguez F, Mosteiro L, Pérez-Cabornero L, Cantalapiedra D, Zorio E, Ramón Y Cajal T, Crespo-Leiro MG, Teulé Á, Lázaro C, Morente MM, Urioste M, Benitez J. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas. J Am Heart Assoc. 2019;8(18):e012875.

142. Padrón-Barthe L, Villalba-Orero M, Gómez-Salinero JM, Domínguez F, Román M, Larrasa-Alonso J, Ortiz-Sánchez P, Martínez F, López-Olañeta M, Bonzón-Kulichenko E, Vázquez J, Martí-Gómez C, Santiago DJ, Prados B, Giovinazzo G, Gómez-Gaviro MV, Priori S, Garcia-Pavia P*, Lara-Pezzi E*. Severe cardiac dysfunction and death caused by ARVC type 5 is improved by inhibition of GSK3B. Circulation 2019;140:1188-1204. *Co-corresponding authors.

143. Lorenzini M, Anastasiou Z, O'Mahony C, Guttman OP, Gimeno JR, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Garcia-Pavia P, Limongelli G, Pavlou M, Elliott PM; Hypertrophic Cardiomyopathy Outcomes investigators. Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population. JAMA Cardiol. 2019 Nov 27. doi: 10.1001/jamacardio.2019.4534. [Epub ahead of print]

144. García-Granja PE, López J, Vilacosta I, Sarriá C, Domínguez F, Ladrón R, Olmos C, Sáez C, Vilches S, García-Arribas D, Cobo-Marcos M, Ramos A, Maroto L, Gómez I, Carrasco M, Garcia-Pavia P, San Román JA. Predictive model of in-hospital mortality in left-sided infective endocarditis. Rev Esp Cardiol 2019 Dec 14. pii: S1885-5857(19)30369-X. doi: 10.1016/j.rec.2019.

145. Lamiquiz-Moneo I, Restrepo-Córdoba MA, Mateo-Gallego R, Bea AM, Del Pino Alberiche-Ruano M, Garcia-Pavia P, Cenarro A, Martín C, Civeira F, Sánchez-Hernández RM. Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia. Atherosclerosis. 2020;292:143-151.

146. Boldrini M, Cappelli F, Chacko L, Restrepo-Cordoba MA, Lopez-Sainz A, Giannoni A, Aimo A, Baggiano A, Martinez-Naharro A, Whelan C, Quarta C, Passino C, Castiglione V, Chubuchnyi V, Spini V, Taddei C, Vergaro G, Petrie A, Ruiz-Guerrero L, Moñivas V, Mingo-Santos S, Mirelis JG, Dominguez F, Gonzalez-Lopez E, Perlini S, Pontone G, Gillmore J, Hawkins PN, Garcia-Pavia P, Emdin M, Fontana M. Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020;13:909- 920.

147. Fernández-Vázquez D, Ferrero-Gregori A, Álvarez-García J, Gómez-Otero I, Vázquez R, Delgado Jiménez J, Worner Diz F, Bardají A, García-Pavía P, Bayés-Genís A, González-Juanatey JR, Cinca J, Pascual Figal DA. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). 2020 73(7):561-568.

148. Dominguez F, Zorio E, Jimenez-Jaimez J, Salguero-Bodes R, Zwart R, Gonzalez-Lopez E, Molina P, Bermúdez-Jiménez F, Delgado JF, Braza-Boïls A, Bornstein B, Toquero J, Segovia J, Van Tintelen JP, Lara-Pezzi E, Garcia-Pavia P. Clinical characteristics and determinants of phenotype in TMEM43 Arrhythmogenic right ventricular cardiomyopathy type 5. Heart Rhythm. 2020;17:945-954.

149. López-Sainz Á, Hernandez-Hernandez A, Gonzalez-Lopez E, Domínguez F, Restrepo-Cordoba MA, Cobo-Marcos M, Gómez-Bueno M, Hernandez-Perez FJ, Oteo JF, Mirelis JG, Cavero MA, Moñivas V, Mingo Santos S, de Haro-Del Moral FJ, Krsnik I, Salas C, Bornstein B, Briceño A, López JA, Vázquez J, Alonso-Pulpón L, Segovia J, Garcia-Pavia P. Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center. Rev Esp Cardiol (Engl Ed). 2020 Apr 18. pii: S1885-5857(20)30098-0. doi: 10.1016/j.rec.2019.12.020. [Epub ahead of print] English, Spanish.

150. Garcia-Lunar I, Blanco I, Fernández-Friera L, Prat-Gonzàlez S, Jordà P, Sánchez J, Pereda D, Pujadas S, Rivas M, Solé-Gonzalez E, Vázquez J, Blázquez Z, García-Picart J, Caravaca P, Escalera N, Garcia-Pavia P, Delgado J, Segovia-Cubero J, Fuster V, Roig E, Barberá JA, Ibanez B, García-Álvarez A. Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial. JACC Basic Transl Sci. 2020;5:317-27.

151. Salazar-Mendiguchía J, Ochoa JP, Palomino-Doza J, Domínguez F, Díez-López C, Akhtar M, Ramiro-León S, Clemente MM, Pérez-Cejas A, Robledo M, Gómez-Díaz I, Peña-Peña ML, Climent V, Salmerón-Martínez F, Hernández C, García-Granja PE, Mogollón MV, Cárdenas-Reyes I, Cicerchia M, García-Giustiniani D, Lamounier A Jr, Gil-Fournier B, Díaz-Flores F, Salguero R, Santomé L, Syrris P, Olivé M, García-Pavía P, Ortiz-Genga M, Elliott PM, Monserrat L; GENESCOPIC Research Group. Mutations in TRIM63 Cause an Autosomal-Recessive Form of Hypertrophic Cardiomyopathy Heart. 2020 May 25:heartjnl-2020-316913. doi: 10.1136/heartjnl-2020-316913.

152. Barriales-Villa R, Ochoa JP, Larrañaga-Moreira JM, Salazar-Mendiguchía J, Díez-López C, Restrepo-Córdoba MA, Álvarez-Rubio J, Robles-Mezcua A, Olmo-Conesa MC, Nicolás-Rocamora E, Sanz J, Villacorta E, Gallego-Delgado M, Yotti R, Espinosa MÁ, Manovel A, Rincón-Díaz LM, Jiménez-Jaimez J, Bermúdez-Jiménez FJ, Basurte-Elorz MT, Climent-Payá V, García-Álvarez MI, Rodríguez-Palomares JF, Limeres-Freire J, Pérez-Guerrero A, Cantero-Pérez EM, Peña-Peña ML, Palomino-Doza J, Crespo-Leiro MG, García-Pinilla JM, Zorio E, Ripoll-Vera T, García-Pavía P, Ortiz-Genga M, Monserrat L. Risk Predictors in a Spanish Cohort With Cardiac Laminopathies. The REDLAMINA Registry. Rev Esp Cardiol 2020 Jun 29;S1885-5857(20)30257-7.

153. Álvarez-García J, Valero MJ, Solé-González E, Ferrero-Gregori A, Vives-Borrás M, Vázquez-García R, González-Juanatey JR, García-Pavía P, Pascual-Figal D, Bover R, Bascompte R, Delgado J, Bardají A, Pérez-Villa F, Zamorano JL, Crespo-Leiro MG, Sánchez PL, García-Osuna A, Robledo-Escobar LA, Bayés de Luna A, Martínez-Sellés M, Cinca J, on behalf of the investigators of the Spanish Heart Failure Network (REDINSCOR II). Prevalence, clinical profile and prognostic implications of interatrial block in patients admitted for heart failure. REC CardioClinics. 2020;55:155-64.

154. Lopez-Sainz A, Dominguez F, Lopes LR, Ochoa JP, Barriales-Villa R, Climent V, Linschoten M, Tiron C, Chiriatti C, Marques N, Rasmussen TB, Espinosa MÁ, Beinart R, Quarta G, Cesar S, Field E, Garcia-Pinilla JM, Bilinska Z, Muir AR, Roberts AM, Santas E, Zorio E, Peña-Peña ML, Navarro M, Fernandez A, Palomino-Doza J, Azevedo O, Lorenzini M, García-Álvarez MI, Bento D, Jensen MK, Méndez I, Pezzoli L, Sarquella-Brugada G, Campuzano O, Gonzalez-Lopez E, Mogensen J, Kaski JP, Arad M, Brugada R, Asselbergs FW, Monserrat L, Olivotto I, Elliott PM, Garcia-Pavia P. Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis. J Am Coll Cardiol. 2020;76:186-197.

155. Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind,
placebo-controlled, phase 3 trial. Lancet. 2020;396:759-69.

156. Damy T, Garcia-Pavia P, Hanna M, Judge DP, Merlini G, Gundapaneni B, Patterson TA, Riley S, Schwartz JH, Sultan MB, Witteles R. Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study. Eur J Heart Fail. 2020 Oct 18. doi: 10.1002/ejhf.2027

157. MacGrogan D, Martínez-Poveda B, Desvignes JP, Fernandez-Friera L, Gomez MJ, Gil Vilariño E, Callejas Alejano S, García-Pavía P, Solis J, Lucena J, Salgado D, Collod-Béroud G, Faure E, Théron A, Torrents J, Avierinos JF, Montes L, Dopazo A, Fuster V, Ibáñez B, Sánchez-Cabo F, Zaffran S, de la Pompa JL. Identification of a peripheral blood gene signature predicting aortic valve calcification. Physiol Genomics. 2020 Oct 12. doi: 10.1152/physiolgenomics.00034.2020. Online ahead of print.

158. Akhtar MM, Lorenzini M, Cicerchia M, Ochoa JP, Hey TM, Sabater Molina M, Restrepo-Cordoba MA, Dal Ferro M, Stolfo D, Johnson R, Larrañaga-Moreira JM, Robles-Mezcua A, Rodriguez-Palomares JF, Casas G, Peña-Peña ML, Lopes LR, Gallego-Delgado M, Franaszczyk M, Laucey G, Rangel-Sousa D, Basurte M, Palomino-Doza J, Villacorta E, Bilinska Z, Limeres Freire J, Garcia Pinilla JM, Barriales-Villa R, Fatkin D, Sinagra G, Garcia-Pavia P, Gimeno JR, Mogensen J, Monserrat L, Elliott PM. Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene. Circ Heart Fail. 2020 Online ahead of print.

159. Lotan D, Salazar-Mendiguchía J, Mogensen J, Rathore F, Anastasakis A, Kaski J, Garcia-Pavia P, Olivotto I, Charron P, Biagini E, Baban A, Limongelli G, Ashram W, Wasserstrum Y, Galvin J, Zorio E, Iacovoni A, Monserrat L, Spirito P, Iascone M, Arad M. Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European Registry. Circ Genom Prescis Med 2020 Online ahead of print.

160. Garcia-Pavia P, Domínguez F, Gonzalez-Lopez E. Transthyretin amyloid cardiomyopathy. Med Clin (Barc). 2020 Online ahead of print.

161. Verdonschot JAJ, Merlo M, Dominguez F, Wang P, Henkens MTHM, Adriaens ME, Hazebroek MR, Masè M, Escobar LE, Cobas-Paz R, Derks KWJ, van den Wijngaard A, Krapels IPC, Brunner HG, Sinagra G, Garcia-Pavia P, Heymans SRB. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences. Eur Heart J. 2020 Nov 6:ehaa841. doi: 10.1093/eurheartj/ehaa841. Online ahead of print.

162. Cobo-Marcos M, Zegri-Reiriz I, Remior-Perez P, Garcia-Gomez S, Garcia-Rodriguez D, Dominguez-Rodriguez F, Martin-Garcia A, Garcia-Pavia P, Segovia-Cubero J. Usefulness of natriuresis to predict in-hospital diuretic resistance. Am J Cardiovasc Dis. 2020 Oct 15;10(4):350-355.

(Última modificación:12/01/2021)